Copyright Reports & Markets. All rights reserved.

Dynamics in Post-pandemic Global Anti-Viral Drugs Industry: Supply and Demand, Markets and Prices 2021-2027

Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Anti-Viral Drugs Market Status and Forecast (2016-2027)
      • 1.3.2 Global Anti-Viral Drugs Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Anti-Viral Drugs Supply by Company

    • 2.1 Global Anti-Viral Drugs Sales Value by Company
    • 2.2 Anti-Viral Drugs Sales Area of Main Manufacturers
    • 2.3 Trend of Concentration Rate

    3 Global and Regional Anti-Viral Drugs Market Status by Category

    • 3.1 Anti-Viral Drugs Category Introduction
      • 3.1.1 Nucleotide Polymerase Inhibitor
      • 3.1.2 Reverse Transcriptase Inhibitor
      • 3.1.3 Protease Inhibitor
    • 3.2 Global Anti-Viral Drugs Market by Category
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional Anti-Viral Drugs Market Status by End User/Segment

    • 4.1 Anti-Viral Drugs Segment by End User/Segment
      • 4.1.1 Oral Use
      • 4.1.2 Injection Use
    • 4.2 Global Anti-Viral Drugs Market by End User/Segment
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global Anti-Viral Drugs Market Status by Region

    • 5.1 Global Anti-Viral Drugs Market by Region
    • 5.2 North America Anti-Viral Drugs Market Status
    • 5.3 Europe Anti-Viral Drugs Market Status
    • 5.4 Asia Pacific Anti-Viral Drugs Market Status
    • 5.5 Central & South America Anti-Viral Drugs Market Status
    • 5.6 Middle East & Africa Anti-Viral Drugs Market Status

    6 North America Anti-Viral Drugs Market Status

    • 6.1 North America Anti-Viral Drugs Market by Country
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Anti-Viral Drugs Market Status

    • 7.1 Europe Anti-Viral Drugs Market by Country
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Anti-Viral Drugs Market Status

    • 8.1 Asia Pacific Anti-Viral Drugs Market by Country
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Anti-Viral Drugs Market Status

    • 9.1 Central & South America Anti-Viral Drugs Market by Country
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Anti-Viral Drugs Market Status

    • 10.1 Middle East & Africa Anti-Viral Drugs Market by Country
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Sales Channel, Distributors and Buyers

    • 11.1 Sales Channel
      • 11.1.1 Direct Sales
      • 11.1.2 Channel Sales
    • 11.2 Anti-Viral Drugs Distributors
    • 11.3 Anti-Viral Drugs Buyers

    12 Global Anti-Viral Drugs Market Forecast by Category and by End User/Segment

    • 12.1 Global Anti-Viral Drugs Sales Value Forecast (2022-2027)
    • 12.2 Global Anti-Viral Drugs Forecast by Category
    • 12.3 Global Anti-Viral Drugs Forecast by End User/Segment

    13 Global Anti-Viral Drugs Market Forecast by Region/Country

    • 13.1 Global Anti-Viral Drugs Market Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Johnson & Johnson
      • 14.1.1 Company Information
      • 14.1.2 Anti-Viral Drugs Product Introduction
      • 14.1.3 Johnson & Johnson Anti-Viral Drugs Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.1.4 Contact Information
    • 14.2 Pfizer
      • 14.2.1 Company Information
      • 14.2.2 Anti-Viral Drugs Product Introduction
      • 14.2.3 Pfizer Anti-Viral Drugs Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.2.4 Contact Information
    • 14.3 Roche
      • 14.3.1 Company Information
      • 14.3.2 Anti-Viral Drugs Product Introduction
      • 14.3.3 Roche Anti-Viral Drugs Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.3.4 Contact Information
    • 14.4 Novartis
      • 14.4.1 Company Information
      • 14.4.2 Anti-Viral Drugs Product Introduction
      • 14.4.3 Novartis Anti-Viral Drugs Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.4.4 Contact Information
    • 14.5 Merck & Co.
      • 14.5.1 Company Information
      • 14.5.2 Anti-Viral Drugs Product Introduction
      • 14.5.3 Merck & Co. Anti-Viral Drugs Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.5.4 Contact Information
    • 14.6 GlaxoSmithKline
      • 14.6.1 Company Information
      • 14.6.2 Anti-Viral Drugs Product Introduction
      • 14.6.3 GlaxoSmithKline Anti-Viral Drugs Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.6.4 Contact Information
    • 14.7 Sanofi
      • 14.7.1 Company Information
      • 14.7.2 Anti-Viral Drugs Product Introduction
      • 14.7.3 Sanofi Anti-Viral Drugs Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.7.4 Contact Information
    • 14.8 AbbVie
      • 14.8.1 Company Information
      • 14.8.2 Anti-Viral Drugs Product Introduction
      • 14.8.3 AbbVie Anti-Viral Drugs Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.8.4 Contact Information
    • 14.9 Takeda
      • 14.9.1 Company Information
      • 14.9.2 Anti-Viral Drugs Product Introduction
      • 14.9.3 Takeda Anti-Viral Drugs Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.9.4 Contact Information
    • 14.10 Shanghai Pharmaceuticals Holding
      • 14.10.1 Company Information
      • 14.10.2 Anti-Viral Drugs Product Introduction
      • 14.10.3 Shanghai Pharmaceuticals Holding Anti-Viral Drugs Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.10.4 Contact Information
    • 14.11 Yiling Pharmaceutical

    15 Conclusion

    Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Anti-Viral Drugs market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Anti-Viral Drugs market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

    Segmented by Category
    Nucleotide Polymerase Inhibitor
    Reverse Transcriptase Inhibitor
    Protease Inhibitor

    Segmented by End User/Segment
    Oral Use
    Injection Use

    Segmented by Country
    North America
    United States
    Canada
    Mexico
    Europe
    Germany
    France
    UK
    Italy
    Russia
    Spain
    Asia Pacific
    China
    Japan
    Korea
    Southeast Asia
    India
    Australasia
    Central & South America
    Brazil
    Argentina
    Colombia
    Middle East & Africa
    Iran
    Israel
    Turkey
    South Africa
    Saudi Arabia

    Key manufacturers included in this survey
    Johnson & Johnson
    Pfizer
    Roche
    Novartis
    Merck & Co.
    GlaxoSmithKline
    Sanofi
    AbbVie
    Takeda
    Shanghai Pharmaceuticals Holding
    Yiling Pharmaceutical

    Buy now